Hysterectomy for benign disease: clinical practice guidelines from the ă French College of Obstetrics and Gynecology

Xavier Deffieux (), Bertrand Rochambeau, Gautier Chêne, Tristan Gauthier, Samantha Huet, Gery Lamblin, Aubert Agostini, Maxime Marcelli and Francois Golfier
Additional contact information
Xavier Deffieux: Service de gynécologie-obstétrique, médecine de la reproduction [Béclère] - UP11 - Université Paris-Sud - Paris 11 - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) - AP-HP - Hôpital Antoine Béclère [Clamart] - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
Gautier Chêne: ERTICa - Equipe de recherche sur les traitements individualisés des cancers - UdA - Université d'Auvergne - Clermont-Ferrand I
Tristan Gauthier: UP11 - Université Paris-Sud - Paris 11
Gery Lamblin: HFME - Hôpital Femme Mère Enfant [CHU - HCL] - HCL - Hospices Civils de Lyon

Post-Print from HAL

Abstract: Objective: The objective of the study was to draw up French College of ă Obstetrics and Gynecology (CNGOF) clinical practice guidelines based on ă the best available evidence concerning hysterectomy for benign disease. ă Methods: Each recommendation for practice was allocated a grade, which ă depends on the level of evidence (clinical practice guidelines). ă Results: Hysterectomy should be performed by a high-volume surgeon (>10 ă hysterectomy procedures per year) (grade C). Stimulant laxatives taken ă as a rectal enema are not recommended prior to hysterectomy (grade C). ă It is recommended to carry out vaginal disinfection using ă povidone-iodine solution prior to hysterectomy (grade B). Antibiotic ă prophylaxis is recommended during hysterectomy, regardless of the ă surgical approach (grade B). The vaginal or laparoscopic approach is ă recommended for hysterectomy for benign disease (grade B), even if the ă uterus is large and/or the patient is obese (grade C). The choice ă between these two surgical approaches depends on other parameters, such ă as the surgeon's experience, the mode of anesthesia, and organizational ă constraints (duration of surgery and medical economic factors). Vaginal ă hysterectomy is not contraindicated in nulliparous women (grade C) or in ă women with previous cesarean section (grade C). No specific hemostatic ă technique is recommended with a view to avoiding urinary tract injury ă (grade C). In the absence of ovarian disease and a personal or family ă history of breast/ovarian carcinoma, the ovaries should be preserved in ă premenopausal women (grade B). Subtotal hysterectomy is not recommended ă with a view to reducing the risk of peri-or postoperative complications ă (grade B). ă Conclusion: The application of these recommendations should minimize ă risks associated with hysterectomy. (C) 2016 Elsevier Ireland Ltd. All ă rights reserved.

Keywords: Quality (search for similar items in EconPapers)
Date: 2016-07
References: Add references at CitEc
Citations:

Published in European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016, 202, pp.83-91. ⟨10.1016/j.ejogrb.2016.04.006⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01482546

DOI: 10.1016/j.ejogrb.2016.04.006

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().